MFS
Mirabella Financial Services Portfolio holdings
AUM
$953M
1-Year Return
26.75%
This Quarter Return
+3.48%
1 Year Return
+26.75%
3 Year Return
+90.29%
5 Year Return
+169.53%
10 Year Return
–
AUM
$360M
AUM Growth
-$13.9M
(-3.7%)
Cap. Flow
-$33.5M
Cap. Flow
% of AUM
-9.32%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
446
New
281
Increased
28
Reduced
39
Closed
95
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$11.4M |
| 2 |
Fortive
FTV
|
$10.6M |
| 3 |
SPDR S&P Homebuilders ETF
XHB
|
$7.88M |
| 4 |
American Electric Power
AEP
|
$7.75M |
| 5 |
Keurig Dr Pepper
KDP
|
$7.55M |
Top Sells
| 1 |
BGC Group
BGC
|
$38.6M |
| 2 |
First Bancorp
FBP
|
$38.5M |
| 3 |
Ambac
AMBC
|
$24.3M |
| 4 |
OFG Bancorp
OFG
|
$24.1M |
| 5 |
PayPal
PYPL
|
$9.3M |
Sector Composition
| 1 | Financials | 18.72% |
| 2 | Healthcare | 14.98% |
| 3 | Technology | 13.44% |
| 4 | Communication Services | 10% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
PPL Corp
PPL
$26.4B
| $261K | 0.04% |
+9,577
| New | +$261K |
|
227
ALX Oncology
ALXO
$59.4M
| $260K | 0.04% |
+6,882
| New | +$260K |
|
228
Korro Bio
KRRO
$309M
| $260K | 0.04% |
+271
| New | +$260K |
|
229
Cardiff Oncology
CRDF
$148M
| $259K | 0.04% |
+18,248
| New | +$259K |
|
230
EPAM Systems
EPAM
$9.16B
| $258K | 0.04% |
+798
| New | +$258K |
|
231
Trupanion
TRUP
$1.87B
| $258K | 0.04% |
+3,264
| New | +$258K |
|
232
LGI Homes
LGIH
$1.53B
| $257K | 0.04% |
+2,214
| New | +$257K |
|
233
Boston Beer
SAM
$2.45B
| $257K | 0.04% |
+291
| New | +$257K |
|
234
Oracle
ORCL
$670B
| $255K | 0.04% |
+4,271
| New | +$255K |
|
235
AllianceBernstein
AB
$4.26B
| $254K | 0.03% |
+9,379
| New | +$254K |
|
236
Donaldson
DCI
$9.47B
| $254K | 0.03% |
+5,473
| New | +$254K |
|
237
Applied Materials
AMAT
$129B
| $253K | 0.03% |
4,251
-9,410
| -69% | -$560K |
|
238
Brown-Forman Class B
BF.B
$13B
| $253K | 0.03% |
+3,361
| New | +$253K |
|
239
TripAdvisor
TRIP
$2.02B
| $253K | 0.03% |
+12,890
| New | +$253K |
|
240
Intercontinental Exchange
ICE
$99.5B
| $252K | 0.03% |
2,519
-26,272
| -91% | -$2.63M |
|
241
Brown & Brown
BRO
$31.5B
| $250K | 0.03% |
+5,533
| New | +$250K |
|
|
VIE
242
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $250K | 0.03% |
+8,886
| New | +$250K |
|
243
Citizens Financial Group
CFG
$22.3B
| $246K | 0.03% |
+9,717
| New | +$246K |
|
244
Agilent Technologies
A
$36.3B
| $245K | 0.03% |
+2,425
| New | +$245K |
|
245
Annexon
ANNX
$243M
| $244K | 0.03% |
+8,058
| New | +$244K |
|
246
United Therapeutics
UTHR
$17.8B
| $244K | 0.03% |
+2,420
| New | +$244K |
|
247
Nurix Therapeutics
NRIX
$742M
| $240K | 0.03% |
+6,876
| New | +$240K |
|
248
Lennar Class A
LEN
$36.9B
| $239K | 0.03% |
3,019
-944
| -24% | -$74.7K |
|
249
Madrigal Pharmaceuticals
MDGL
$10.1B
| $237K | 0.03% |
+1,992
| New | +$237K |
|
250
General Mills
GIS
$26.8B
| $236K | 0.03% |
+3,827
| New | +$236K |
|